跳至主要内容
临床试验/CTRI/2025/10/095696
CTRI/2025/10/095696尚未招募2 期

Efficacy of Gulmahar Kashaya and Vaitarana Basti in the management of Endometriosis - An Exploratory Clinical Study

Department of Prasuti Tantra evum Stree Roga1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Reduction in endometriotic cyst size in USG (pelvis) findings.

研究概览

简要总结

This clinical trial is being conducted to evaluate the effect of Gulmahar Kashaya and Vaitarana Basti in the management of endometriosis.

Endometriosis is a condition where tissue similar to the uterine lining grows outside the uterus, often causing pain and infertility.

The study will include female patients between 20–40 years of age with ultrasonography-confirmed endometriotic cysts less than 5 cm in size.

The intervention involves administration of Gulmahar Kashaya orally and Vaitarana Basti as part of Yoga Basti procedure.

The main outcome of the study will be reduction in cyst size as seen on ultrasonography. Secondary outcomes will include improvement in pain and quality of life.

This study will help to explore safe and effective Ayurvedic management options for endometriosis.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • USG confirmed cases of endometriotic cyst less than 5 cm.
  • CA-125 less than 200 U per ml
  • Female patients between the age of 20-40 years diagnosed with endometriosis, willing to participate.
  • Patients presenting with any of the complaint of pelvic pain, dysmenorrhea, dysuria, dyspareunia, dyschezia and irregular menstrual cycles along with endometriotic cyst in USG.
  • Those patients who are eligible for Basti karma.

排除标准

  • Patients with malignancy of genital tract.
  • Patients of chronic diseases like uncontrolled hypertension and diabetes mellitus.
  • Pregnant or lactating women.
  • Patients on hormonal therapy.
  • Those patients who are not eligible for Basti karma.

结局指标

主要结局

Reduction in endometriotic cyst size in USG (pelvis) findings.

时间窗: Baseline and one month after completion of three cycles

次要结局

  • Decrease in severity of pain, symptoms of dysmenorrhea, dyspareunia, dysuria, and dyschezia, enhancement of menstrual regularity, and an overall improvement in Quality of Life.(Baseline, after each cycle of procedure and one month after completion of three cycles)

研究者

发起方
Department of Prasuti Tantra evum Stree Roga
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Sadia Kausar

All India Institute of Ayurveda

研究点 (1)

Loading locations...

相似试验